​Revolutionary Drug Delivery System for Rheumatoid Arthritis

On 4th February 2025, the Department of Science & Technology informed that researchers from the Institute of Nano Science and Technology (INST), Mohali, have developed an innovative self-actuating drug delivery system that offers targeted, on-demand treatment for rheumatoid arthritis (RA).

Breakthrough in Targeted RA Treatment

  • The system uses microspheres loaded with methotrexate, a commonly used anti-rheumatic drug, which is released only when inflammation is detected in the joints.
  • Biochemical signals from inflamed joints trigger drug release, ensuring precise treatment while minimizing side effects.
  • The formulation responds to elevated levels of specific enzymes (MMP-2 and MMP-9) during RA flare-ups, offering a controlled, pulsatile ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Buy April 2025 Issue

Already a Member? Login here

Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Be an Annual Subscriber

Related Content